Publikationen

Hoppe, B, Häupl, T, Skapenko, A, Ziemer, S, Tauber, R, Salama, A, Schulze-Koops, H, Burmester, GR, Dörner, T
Fibrinogen and factor XIII A-subunit genotypes interactively influence CRP levels during inflammation.
Ann Rheum Dis 2012; doi:10.1136/annrheumdis-2011-200738
Hoppe, B, Burmester, GR, Häupl, T
Prothrombin 20210G>A genotype and C-reactive protein level.
Blood 2011; 118:4495-6.
Hoppe, B, Häupl, T, Egerer, K, Gruber, R, Kiesewetter, H, Salama, A, Burmester, GR, Dörner, T
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
Ann Rheum Dis 2009; 68:898-903.
Bukreeva, L, Grigorov, A, Kiesewetter, H, Hoppe, B
Association of angiotensin converting enzyme intron 16 insertion/deletion polymorphism with history of fetal loss.
J Renin Angiotensin Aldosterone Syst 2009; 10:237-40.
Hoppe B, Salama A
Sequencing-based typing of HLA.
In: „Methods in Molecular Medicine - 134. Bone Marrow and Stem Cell Transplantation“ 2007; Humana Press Inc., Totowa, New Jersey
Hoppe B, Häupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, Dörner T
Detailed analysis of the variability of peptidylarginine deiminase type IV (PADI4) in German patients with rheumatoid arthritis: A case-control study.
Arthritis Res Ther 2006; 8(2):R34.
Hoppe B, Heymann GA, Radtke H, Kiesewetter H, Dörner T, Salama A
Association of Marburg I polymorphism of factor VII–activating protease with venous thromboembolism is limited to idiopathic events.
Blood 2005; 105:4899.
Hoppe B, Heymann GA, Kiesewetter H, Salama A
Identification and characterization of a novel HLA-DRB1 allele, DRB1*0830.
Tissue Antigens 2005; 66:160-2.
Hoppe B, Tolou F, Radtke H, Kiesewetter H, Dörner T, Salama A
Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolism.
Blood 2005; 105:1549-51.
Hoppe B, Heymann GA, Tolou F, Kiesewetter H, Doerner T, Salama A
High variability of peptidylarginine deiminase 4 (PADI4) in a healthy Caucasian population: Characterisation of 6 new variants of PADI4 exons 2 to 4 by a novel haplotype-specific sequencing-based approach.
J Mol Med 2004; 82:762-7.

Arbeitsgruppenleitung

PD Dr. med. Berthold Hoppe

Charité – Universitätsmedizin Berlin
Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie

Campus Charité Mitte
Charitéplatz 1
D-10117 Berlin

t: +49 30 450 569 094
f: +49 30 450 569 994